UPDATE: Marker Therapeutics (MRKR) - The Catalyst That Didn’t Show Up

Q2 R&D fell 65% to $1.5M and the 1H 2026 APOLLO readout I've been circling since January never printed. A $4.2M Department of War grant is the good news; the burn-rate collapse is the tell.